December 3, 2022
You are here:  Home  >  Banking & Finance  >  Tri-County Public Companies  >  Earnings  >  Current Article

Thousand Oaks’ Amgen just keeps chugging along


Amgen co-founder William K. Bowes Jr. stands watch over the Thousand Oaks campus. Biosimilars are a double-edged sword for Amgen. Never has that been clearer than when the Thousand Oaks-based biotech giant released fourth quarter and 2015 year-end results on Jan. 28. Despite modest fourth-quarter earnings, investors should not worry. Amgen raised projections for 2016…


    This article is only available to Business Times subscribers
  • Subscribers: or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.